171 related articles for article (PubMed ID: 11434218)
1. [Oxygen therapy in the long term treatment of Meniere's disease].
Fattori B; Nacci A; Casani A; Donati C; De Iaco G
Acta Otorhinolaryngol Ital; 2001 Feb; 21(1):1-9. PubMed ID: 11434218
[TBL] [Abstract][Full Text] [Related]
2. Alternobaric oxygen therapy in long-term treatment of Ménière's disease.
Fattori B; De Iaco G; Nacci A; Casani A; Ursino F
Undersea Hyperb Med; 2002; 29(4):260-70. PubMed ID: 12797667
[TBL] [Abstract][Full Text] [Related]
3. Effects of endolymphatic sac drainage with steroids for intractable Meniere's disease: a long-term follow-up and randomized controlled study.
Kitahara T; Kubo T; Okumura S; Kitahara M
Laryngoscope; 2008 May; 118(5):854-61. PubMed ID: 18520184
[TBL] [Abstract][Full Text] [Related]
4. [Long-term audition results in patients with chronic endolymphatic hydrops after selective vestibular neurotomy and endolymphatic sac surgery].
Quaranta N; De Thomasis G; Gandolfi A; Piazza F; Zini C; Quaranta A
Acta Otorhinolaryngol Ital; 2001 Jun; 21(3):131-7. PubMed ID: 11677838
[TBL] [Abstract][Full Text] [Related]
5. [Long-term results of Meniere's disease treatment].
Pal'chyn VT; Papina NA
Vestn Otorinolaringol; 2000; (6):5-7. PubMed ID: 11187078
[TBL] [Abstract][Full Text] [Related]
6. Alternobaric and hyperbaric oxygen therapy in the immediate and long-term treatment of Menière's disease.
Fattori B; De Iaco G; Vannucci G; Casani A; Ghilardi PL
Audiology; 1996; 35(6):322-34. PubMed ID: 9018366
[TBL] [Abstract][Full Text] [Related]
7. Comparison of long-term hearing results after vestibular neurectomy, endolymphatic mastoid shunt, and medical therapy.
Quaranta A; Onofri M; Sallustio V; Iurato S
Am J Otol; 1997 Jul; 18(4):444-8. PubMed ID: 9233483
[TBL] [Abstract][Full Text] [Related]
8. Endolymphatic sac surgery for Ménière's disease: long-term results after primary and revision surgery.
Wetmore SJ
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1144-8. PubMed ID: 19015441
[TBL] [Abstract][Full Text] [Related]
9. Effects of middle ear pressure changes on clinical symptoms in patients with Ménière's disease--a clinical multicentre placebo-controlled study.
Odkvist LM; Arlinger S; Billermark E; Densert B; Lindholm S; Wallqvist J
Acta Otolaryngol Suppl; 2000; 543():99-101. PubMed ID: 10908991
[TBL] [Abstract][Full Text] [Related]
10. [Delayed endolymphatic hydrops].
Giannoni B; Pagnini P; Vannucchi P
Acta Otorhinolaryngol Ital; 1998 Aug; 18(4 Suppl 59):66-70. PubMed ID: 10205936
[TBL] [Abstract][Full Text] [Related]
11. Clinical indicators useful in predicting response to the medical management of Meniere's disease.
Devaiah AK; Ator GA
Laryngoscope; 2000 Nov; 110(11):1861-5. PubMed ID: 11081600
[TBL] [Abstract][Full Text] [Related]
12. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
Convert C; Franco-Vidal V; Bebear JP; Darrouzet V
Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
[TBL] [Abstract][Full Text] [Related]
13. Diameter of the cochlear nerve in endolymphatic hydrops: implications for the etiology of hearing loss in Ménière's disease.
Megerian CA
Laryngoscope; 2005 Sep; 115(9):1525-35. PubMed ID: 16148690
[TBL] [Abstract][Full Text] [Related]
14. [Ablation therapy with gentamycin in the treatment of Meniere's disease].
Leone CA; Mosca F; Mincione A
Acta Otorhinolaryngol Ital; 2000 Oct; 20(5):322-9. PubMed ID: 11284259
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease?
Junicho M; Aso S; Fujisaka M; Watanabe Y
Acta Otolaryngol; 2008 Mar; 128(3):304-8. PubMed ID: 18274917
[TBL] [Abstract][Full Text] [Related]
16. Endolymphatic hydrops in asymptomatic ears in unilateral Ménière's disease.
Friedrichs I; Thornton AR
Laryngoscope; 2001 May; 111(5):857-60. PubMed ID: 11359166
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of the Meniett device in Japanese patients with Meniere's disease and delayed endolymphatic hydrops reported by the Middle Ear Pressure Treatment Research Group of Japan.
Shojaku H; Watanabe Y; Mineta H; Aoki M; Tsubota M; Watanabe K; Goto F; Shigeno K
Acta Otolaryngol; 2011 Mar; 131(3):277-83. PubMed ID: 21319947
[TBL] [Abstract][Full Text] [Related]
18. Effect of reduced atmospheric pressure on patients with fluctuating hearing loss due to Ménière's disease.
Younger R; Longridge NS; Mekjavic I
J Otolaryngol; 1984 Apr; 13(2):76-82. PubMed ID: 6726851
[TBL] [Abstract][Full Text] [Related]
19. Functional outcome of treatment of Ménière's disease with the Meniett pressure generator.
Stokroos R; Olvink MK; Hendrice N; Kingma H
Acta Otolaryngol; 2006 Mar; 126(3):254-8. PubMed ID: 16618650
[TBL] [Abstract][Full Text] [Related]
20. Intratympanic gentamicin for intractable Meniere's disease.
Perez N; Martín E; García-Tapia R
Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
